Athersys

Entity > Corporation > US > New York City New York > Athersys

About Athersys

Athersys, Inc. is an international biotechnology company that is focused in the field of regenerative medicine. They are committed to developing therapeutic products that they believe have best-in-class potential, meaning therapies that have the potential to be safer and more effective than the current standard of care or other products in development, and that may have other advantages, such as superior scalability or ease of administration.

Athersys is Developing the MultiStem Cell Therapy: MultiStem cell therapy, a patented and proprietary allogeneic “off-the-shelf” stem cell product, is our lead platform product and has shown promise for treating indications in the neurological, inflammatory and immune, and cardiovascular disease areas, as well as certain other critical care conditions. MultiStem is currently being evaluated in several clinical-stage programs.

Athersys' Business Strategy: Their principal business objective is to discover, develop and commercialize novel therapeutic products for disease indications that represent significant areas of clinical need and where they believe there is a substantial commercial opportunity.

Founding: Athersys was founded in 1995. They are headquartered in Cleveland, Ohio.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Athersys

Company Attribute Value
Address StreetAddress: 3201 Carnegie Ave, AddressLocality: Cleveland, AddressRegion: Ohio, PostalCode: 44115, AddressCountry: United States
Founding Date 1995
Name Athersys
Number Of Employees 104
Revenue $8,426,000 USD
Ticker Symbol NASDAQ: ATHX
Url athersys
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google
Wikidata wikidata

Athersys

us

New York City, US
17 Jul 2024

New York City, US
17 Jul 2024

Athersys

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.athersys.com › home
Athersys, Inc.
Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human ...
https://www.fiercebiotech.com › biotech › athersys-files...
Athersys files for bankruptcy, sells assets to Healios
Jan 9, 2024 — With Athersys' days now numbered, Healios has swooped in and bought up all of the biotech's assets for $2 million via a credit bid.
https://www.athersys.com › news-and-media
News & Media
Press Releases ... Athersys Reports Third Quarter 2023 Financial Results and Bu... ... Athersys Extends Near Term Liquidity with Proceeds from Warr... ... Athersys ...
https://www.athersys.com › multistem-therapy › clinical...
Clinical Pipeline - MultiStem
We have established a diverse portfolio of diseases and conditions for treatment in the area of regenerative medicine area, with an emphasis on treating ...
https://www.biospace.com › News › Deals
Athersys Adds to Surge of Biotechs Filing for Bankruptcy ...
Jan 9, 2024 — Continuing the surge of biotech bankruptcies, Athersys filed for Chapter 11 on January 5, according to an SEC filing. All assets of ...
https://www.athersys.com › investors › press-releases
Investors - Press Releases
Press Releases · November 16, 2023. Athersys Reports Third Quarter 2023 Financial Results and Business Highlights · October 16, 2023 · October 10, 2023.
https://www.linkedin.com/company/athersys
Athersys
We are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. Through ...
https://www.athersys.com › news-and-media › video
News & Media - Video
https://www.athersys.com › our-company › overview
About - Our Purpose
We are an international biotechnology company that is focused in the field of regenerative medicine. We are committed to developing therapeutic products ...
https://www.facebook.com/Athersys/
Athersys | Cleveland OH
Athersys, Cleveland, Ohio. 698 likes · 23 were here. Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class th.
Related Searches
Related Searches
Athersys lawsuit
Athersys Reddit
Athersys news
Knowledge Panel
Knowledge Panel

Athersys Inc (Biotechnology company)

athersys.com/home/default.aspx

  • Stock price : ATHXQ (OTCMKTS) $0.00 0.00 (-16.67%)Jul 16, 4:00 PM EDT - Disclaimer
  • Founded : 1995
  • Headquarters : Cleveland, OH

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 89788